Herbisol200 ml

Herbisol is a traditional (Unani) pediatric syrup formulation ('Sharbat' meaning syrup and 'Atfal' meaning children) that has conventionally been used as a general tonic and mild digestive/symptomatic-relief preparation for infants and young children. Its traditional uses include:

• Traditional/adjunct use: as a mild digestive aid for occasional infant colic, gas, or minor digestive discomfort.
• Traditional/adjunct use: as a general appetite and wellness tonic in traditional pediatric practice.
• Traditional/adjunct use: for mild, self-limiting symptomatic relief in young children as part of traditional care.

These uses are based on traditional/Unani practice rather than controlled clinical trial evidence. A standardized, independently verified composition and formal evidence base for Herbisol could not be confirmed from authoritative regulatory sources; the indications above should be understood as conservative, evidence-limited traditional uses rather than established pharmacological claims. Herbisol does not replace evidence-based pediatric medical care for significant illness.

Sharbat Atfal is a traditional Unani polyherbal syrup formulation. Because it is a traditional preparation, exact standardized composition and quantitative ingredient content vary by manufacturer and could not be independently verified from an authoritative regulatory source. Traditional formulations of this type typically contain a combination of botanical/herbal extracts in a sweetened syrup base. Patients and caregivers should refer to the specific product label/pack insert of the marketed brand of Sharbat Atfal for the exact list of ingredients and their quantities.

Herbisol is a traditional Unani (Greco-Arabic traditional medicine system) pediatric syrup. The name translates literally as 'syrup for children.' It is conventionally formulated and marketed as a general tonic and mild digestive/symptomatic-relief preparation intended for infants and young children, used within traditional medicine practice. It is not an FDA-approved conventional pharmaceutical drug, and its therapeutic claims rest on traditional use rather than robust modern clinical trial data. Any use of Herbisol should be conservative and should not delay evidence-based medical evaluation of a sick child.

Herbisol belongs to the traditional/Unani (herbal-polyherbal) pediatric tonic and digestive-aid category. It is classified as a traditional medicine preparation rather than a conventional single-molecule pharmaceutical agent.

As a traditional polyherbal formulation, the precise pharmacological mechanism of Sharbat Atfal has not been characterized through standardized modern pharmacological studies, and no single active pharmacological constituent with an established mechanism of action has been confirmed from authoritative sources. Traditional Unani theory attributes digestive and tonic effects to the combined botanical constituents, but this has not been validated by controlled pharmacokinetic or pharmacodynamic research. Caregivers should not assume Sharbat Atfal has a specific, proven pharmacological action equivalent to a regulated drug.

Herbisol is administered orally, usually measured with the dosing device supplied with the product. It should be given exactly as directed on the product label or by the prescribing/advising practitioner, and not mixed with other medicines unless advised.

Formal, well-verified drug-interaction data for Herbisol are not available from authoritative pharmacological sources, as it is a traditional polyherbal preparation rather than a single characterized drug substance. As a general precaution, caregivers should inform the treating physician about all other medicines, supplements, or traditional remedies being given to the child before starting Herbisol, to allow the physician to assess for any theoretical interaction, particularly with prescribed pediatric medications.

Because Herbisol is a traditional herbal preparation, a formally studied and complete adverse-effect profile is not available. Possible effects that have been reported anecdotally with similar traditional polyherbal pediatric syrups include:

• Mild gastrointestinal upset (e.g., loose stools, mild stomach discomfort).
• Allergic-type reactions in sensitive children (e.g., skin rash, itching) — see Contraindications.

If any unusual or concerning reaction occurs after giving Herbisol, discontinue use and seek medical advice promptly.

Herbisol is formulated for infants and young children and is not indicated for use during pregnancy or lactation in the mother. Safety data for maternal use during pregnancy or breastfeeding are not established. If a breastfeeding mother is considering any related product, she should consult a physician before use; this field is not clinically applicable to the pediatric patient population for whom Herbisol is intended.

Herbisol should be used with the following precautions:

• Pediatric dosing of any preparation, traditional or conventional, should always be guided by a healthcare provider and appropriate for the child's age and weight.
• Use only under the guidance of a qualified physician or traditional medicine (Unani) practitioner.
• Discontinue Herbisol immediately if any adverse reaction occurs and seek medical advice.
• Herbisol does not replace evidence-based pediatric medical care for significant illness — fever, persistent vomiting or diarrhea, poor feeding, or lethargy in a child require prompt medical evaluation regardless of traditional remedy use.
• Do not exceed the recommended dose or duration on the product label without medical advice.

Specific overdose data for Herbisol have not been established, as it is a traditional preparation without formal toxicology studies. If a child ingests significantly more than the recommended amount of Herbisol, or develops any concerning symptoms, seek immediate medical attention or contact a poison control center/emergency services rather than attempting home treatment.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children.

Neonates and very young infants: use of Herbisol is not advised without direct professional guidance, given limited safety data at this age (see Contraindications).

Children with known allergies: caution is advised in children with known sensitivities to herbal extracts or sweeteners, as formulations may vary by manufacturer (see Contraindications).

Children with chronic illness or on other medications: a physician should be consulted before starting Herbisol to rule out any theoretical interaction or contraindication.

Duration of use of Herbisol should follow the specific product label or the advice of the prescribing physician or traditional medicine practitioner. It is generally intended for short-term, intermittent use for mild symptomatic relief rather than prolonged continuous therapy. If symptoms persist beyond a few days, or worsen, medical evaluation should be sought rather than continuing Herbisol indefinitely.

Traditional/Unani polyherbal pediatric tonic and digestive-aid preparation.

A specific, scientifically validated mode of action for Sharbat Atfal has not been established through modern pharmacological research, as it is a traditional polyherbal formulation. Traditional Unani practice attributes carminative, digestive, and mild tonic effects to its combined botanical constituents, but this has not been confirmed through controlled studies.

Herbisol is specifically formulated and marketed for use in infants and young children as a traditional tonic/digestive-aid preparation. However, formal safety and efficacy data equivalent to modern clinical trial standards have not been established for this age group. Use should be guided by the product label and a qualified physician or traditional medicine practitioner, with particular caution in neonates and very young infants (see Contraindications and Precautions). Any signs of serious illness in a child (fever, persistent vomiting/diarrhea, poor feeding, lethargy) require prompt medical evaluation rather than reliance on Herbisol alone.